ArticleNature medicine2026
Author Correction: Teclistamab-based induction treatment in transplant-eligible, newly diagnosed multiple myeloma: a phase 2 trial.
Abstract readPublished Erratum
In one paragraph
Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Erratum for
Authors and funding
32 authors.
Marc S Raab *Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany. marc.raab@med.uni-heidelberg.de.ORCID http://orcid.org/0000-0003-4181-6922
Niels Weinhold *Heidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-5464-3234
K Martin KortümDepartment of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-7011-0286
Jan KrönkeDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.ORCID http://orcid.org/0000-0002-4649-0506
Roland FenkDepartment of Hematology, Oncology and Clinical Immunology, University Hospital Düsseldorf, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany.
Katja WeiselUniversity Medical Center Hamburg-Eppendorf, Hamburg, Germany.ORCID http://orcid.org/0000-0001-9422-6614
Lilli PodolaHeidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.
Uta BertschHeidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.
Alexander BrobeilInstitute of Pathology, University Hospital Heidelberg, Heidelberg, Germany.
Julia MersiDepartment of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.
Stefanie HuhnHeidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.
Ryan ArlinghausCoordination Centre for Clinical Trials (KKS), University Hospital Heidelberg, Heidelberg, Germany.
Michael HundemerHeidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.
Stephan R BohlDepartment of Hematology, Oncology, and Tumor Immunology, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Elias K MaiHeidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-6226-1252
Natalie SchubDepartment of Internal Medicine II, Division of Stem Cell Transplantation and Immunotherapy, Universitätsklinikum Schleswig-Holstein (UKSH) Campus Kiel, Kiel, Germany.
Johannes WaldschmidtDepartment of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0001-5340-1818
Florian BassermannDepartment of Medicine III, TUM Klinikum, Technische Universität München, München, Germany.ORCID http://orcid.org/0000-0003-4435-2609
Carsten Müller-TidowHeidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0002-7166-5232
Christoph HeuckJohnson & Johnson, Spring House, PA, USA.
Caline SakabedoyanJohnson & Johnson, Paris, France.
Josephine KhanJohnson & Johnson, High Wycombe, UK.
Elena ErshovaJohnson & Johnson, Beerse, Belgium.
Bas D KosterJohnson & Johnson, Leiden, The Netherlands.ORCID http://orcid.org/0000-0002-3889-5132
Monika EngelhardtDepartment of Hematology, Oncology and Stem Cell Transplantation, Medical Centre - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Mathias HänelDepartment of Internal Medicine III, Klinikum Chemnitz, Chemnitz, Germany.
Hans SalwenderAsklepios Tumorzentrum Hamburg, Asklepios Klinik Altona and Asklepios Klinik St. Georg, Hamburg, Germany.ORCID http://orcid.org/0000-0001-7803-0814
Raphael TeipelMedizinische Klinik und Poliklinik I Universitätsklinikum Carl Gustav Carus an der Technische Universität Dresden, Dresden, Germany.
Hartmut GoldschmidtHeidelberg Myeloma Center and GMMG Study Group, Department of Medicine V, Heidelberg University Hospital and Medical Faculty Heidelberg, Heidelberg, Germany.ORCID http://orcid.org/0000-0003-0961-0035
Hermann EinseleDepartment of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany.ORCID http://orcid.org/0000-0002-7680-0819
Leo RascheDepartment of Internal Medicine II, University Hospital of Würzburg, Würzburg, Germany. Rasche_L@ukw.de.ORCID http://orcid.org/0000-0002-9536-9649
GMMG-HD10/DSMM-XX (MajesTEC-5) investigators
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Identifiers
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.